European Haemophilia Consortium/X
Jul 23, 2025, 10:59
EHC Warns of Severe Impact from Von Willebrand Factor Supply Delays
The European Haemophilia Consortium (EHC) shared a post on X:
“Supply delays of Von Willebrand Factor can cause severe consequences for Von Willebrand Disease patients – worsening health, irreversible damage, hospitalisations, even death. Health systems must recognise Von Willebrand Factor as Critical Medicine.”
Stay informed with Hemostasis Today.
-
Jun 20, 2026, 10:48Alliah Czarielle Formalejo: Loving People Without Defining Them
-
Jun 20, 2026, 10:18Luciano Martelotto: CD200R1, IL-17A, and the Future of Cancer Thrombosis Prevention
-
Jun 20, 2026, 10:09Nicolle Davis: Celebrating the Team Behind Life-Saving Mobile Stroke Care
-
Jun 20, 2026, 07:09Norio Nakatsuji: LRP5 Inhibition Shows Promise for Safer Blood-Thinning Strategies
-
Jun 20, 2026, 07:02Sex Hormone Influences on Venous Thrombosis in Episode 32 of CLOT Conversations – Thrombosis Canada
-
Jun 20, 2026, 06:57Shayan Mohammadmoradi: Excited to Share New Insights Into Platelet α-Granule Integrity and Aortic Aneurysms at ISTH 2026
-
Jun 20, 2026, 06:46The Inspiring Journey of Padma Shri Dr. Suresh Hanagavadi – Karnataka Hemophilia Society Davanagere
-
Jun 20, 2026, 06:39Rethinking Physical Activity in the Era of Modern Hemophilia Care – Hematology Advisor
-
Jun 20, 2026, 06:29Bernard Slater Jr.: Hope on the Horizon as Hemophilia B Treatment Continues to Evolve